| ASSET | QUARTER | % RETURN |
|---|---|---|
NVR (NVR) | Q1 1991 | 266.67% |
Flanigans Enterprises (BDL) | Q1 1991 | 199.96% |
Mesa Laboratories (MLAB) | Q1 1991 | 191.73% |
Oppenheimer (OPY) | Q1 1991 | 184.2% |
Hovnanian Enterprises (HOV) | Q1 1991 | 181.82% |
Magna International (MGA) | Q1 1991 | 173.66% |
Jack Henry & Associates (JKHY) | Q1 1991 | 159.29% |
Celldex Therapeutics (CLDX) | Q1 1991 | 156.52% |
Toll Brothers (TOL) | Q1 1991 | 152.32% |
Air T (AIRT) | Q1 1991 | 150.4% |
OraSure Technologies (OSUR) | Q1 1991 | 144.16% |
Data I/O (DAIO) | Q1 1991 | 141.18% |
CECO Environmental (CECO) | Q1 1991 | 133.32% |
Winnebago Industries (WGO) | Q1 1991 | 129.99% |
Mitek Systems (MITK) | Q1 1991 | 126% |
Semtech (SMTC) | Q1 1991 | 125.04% |
Tat Techno (TATT) | Q1 1991 | 125% |
ImmuCell (ICCC) | Q1 1991 | 122.22% |
STAAR Surgical (STAA) | Q1 1991 | 116.52% |
Dominari (DOMH) | Q1 1991 | 113.33% |
Amgen (AMGN) | Q1 1991 | 111.7% |
Advanced Micro Devices (AMD) | Q1 1991 | 110% |
CEL-SCI (CVM) | Q1 1991 | 100% |
Compass Therapeutics (CMPX) | Q1 1991 | 100% |
GT Biopharma (GTBP) | Q1 1991 | 100% |
